These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11785482)

  • 1. Osteoporosis and HIV disease.
    Cheonis N
    BETA; 2001; 14(2):26-34. PubMed ID: 11785482
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteoporosis and HIV disease.
    Cheonis N
    BETA; 2001; 14(2):26-34. PubMed ID: 11702764
    [No Abstract]   [Full Text] [Related]  

  • 3. Identifying and managing morphologic complications of HIV and HAART.
    Currier J; Carpenter C; Daar E; Kotler D; Wanke C
    AIDS Read; 2002 Mar; 12(3):114-9, 124-5. PubMed ID: 11966241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies link HIV drugs and bone density problems. Research examining HIV in children and women.
    AIDS Alert; 2003 Jul; 18(7):88-9. PubMed ID: 12846197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and bone disease.
    Compston J
    J Intern Med; 2016 Oct; 280(4):350-8. PubMed ID: 27272530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balancing the health benefits and the risks of obesity among HIV-infected youth.
    Smit E
    J Am Diet Assoc; 2004 Oct; 104(10):1549-53. PubMed ID: 15389412
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone mineral density increases in HIV-infected children treated with long-term combination antiretroviral therapy.
    Bunders MJ; Frinking O; Scherpbier HJ; van Arnhem LA; van Eck-Smit BL; Kuijpers TW; Zwinderman AH; Reiss P; Pajkrt D
    Clin Infect Dis; 2013 Feb; 56(4):583-6. PubMed ID: 23097583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic complications of HIV-1 antiretroviral therapy: the lipodystrophy syndrome.
    Borderi M; Verucchi G; Tadolini M; Spinosa S; Fortunato L; Talò S; Chiodo F
    New Microbiol; 2001 Jul; 24(3):303-15. PubMed ID: 11497090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
    AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of body morphology changes and lipid abnormalities associated with HIV Infection and its therapies.
    Wohl DA
    Top HIV Med; 2004; 12(3):89-93. PubMed ID: 15310940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
    Guo FP; Yu XB; Luo L; Han Y; Qiu ZF; Zuo LY; Li YL; Yu W; Li TS
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):649-52. PubMed ID: 20979781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
    Su YB; Xie J; Han Y; Qiu ZF; Li YL; Song XJ; Yu W; Li TS
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1155-8. PubMed ID: 22883000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy-induced lipodystrophy.
    Behera V; Randive M; Sundaray S; Murty MS
    BMJ Case Rep; 2015 Feb; 2015():. PubMed ID: 25678613
    [No Abstract]   [Full Text] [Related]  

  • 14. Practical management of lipid abnormalities in HIV--case studies.
    Peters BS
    Int J STD AIDS; 2005 Oct; 16 Suppl 1():31-3; discussion 33-4, 41-3. PubMed ID: 16238829
    [No Abstract]   [Full Text] [Related]  

  • 15. Can the bone disease experienced by HIV-infected patients be attributed to HAART?
    Monier P
    HIV Clin; 2003; 15(3):1-3. PubMed ID: 12945528
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone disease and HIV infection.
    Rojo P; Ramos JT
    Clin Infect Dis; 2006 Jul; 43(1):111-2; author reply 113-4. PubMed ID: 16758430
    [No Abstract]   [Full Text] [Related]  

  • 17. Accelerated bone mineral loss in HIV-positive patients.
    Laurence J
    AIDS Read; 2000 Apr; 10(4):192, 200. PubMed ID: 10808594
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone disease in the setting of HIV infection: update and review of the literature.
    Castronuovo D; Cacopardo B; Pinzone MR; Di Rosa M; Martellotta F; Schioppa O; Moreno S; Nunnari G
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2413-9. PubMed ID: 24089217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mass in HIV-infected patients: focus on the role of therapy and sex.
    Vescini F; Borderi M; Buffa A; Sinicropi G; Tampellini L; Chiodo F; Caudarella R
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):405-7. PubMed ID: 12843753
    [No Abstract]   [Full Text] [Related]  

  • 20. The metabolic puzzle during the evolution of HIV infection.
    Salas-Salvadó J; García-Lorda P
    Clin Nutr; 2001 Oct; 20(5):379-91. PubMed ID: 11534932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.